NMPA Approval - Global Market Updates

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.

Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - August 20, 2024 0

AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...

CCPA Fines Sriram’s IAS ₹3 Lakh for Misleading UPSC Results Claims

John - August 18, 2024

India-Sri Lanka Joint Military Exercise MITRA SHAKTI Begins in Maduru Oya

John - August 12, 2024

MoS Savitri Thakur Honors 161 Women Field Functionaries for Advancing Women and Child Development

John - August 14, 2024

Airtel Expands Wi-Fi Service to 2 Million New Homes in West Bengal

John - August 7, 2024

Tag: NMPA Approval

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

EDITOR PICKS

CCPA Fines Sriram’s IAS ₹3 Lakh for Misleading UPSC Results Claims

India-Sri Lanka Joint Military Exercise MITRA SHAKTI Begins in Maduru Oya

MoS Savitri Thakur Honors 161 Women Field Functionaries for Advancing Women and Child Development

Airtel Expands Wi-Fi Service to 2 Million New Homes in West Bengal

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY